Literature DB >> 9931011

Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).

M Ramjeesingh1, C Li, E Garami, L J Huan, K Galley, Y Wang, C E Bear.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) functions as an ATPase and as a chloride channel. It has been hypothesized, on the basis of electrophysiological findings, that the catalytic activity of CFTR is tightly coupled to the opening and closing of the channel gate. In the present study, to determine the structural basis for the ATPase activity of CFTR, we assessed the effect of mutations within the "Walker A" consensus motifs on ATP hydrolysis by the purified, intact protein. Mutation of the lysine residue in the "Walker A" motif of either the first nucleotide binding fold (CFTRK464A) or the second nucleotide binding fold (CFTRK1250A) inhibited the ATPase activity of the purified intact CFTR protein significantly, by greater than 50%. This finding suggests that the two nucleotide binding folds of CFTR are functioning cooperatively in catalysis. However, the rate of channel gating was only significantly inhibited in one of these purified mutants, CFTRK1250A, suggesting that ATPase activity may not be tightly coupled to channel gating as previously hypothesized.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931011     DOI: 10.1021/bi982243y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

Review 1.  CFTR channel gating: incremental progress in irreversible steps.

Authors:  L Csanády; D C Gadsby
Journal:  J Gen Physiol       Date:  1999-07       Impact factor: 4.086

2.  A conditional probability analysis of cystic fibrosis transmembrane conductance regulator gating indicates that ATP has multiple effects during the gating cycle.

Authors:  D J Hennager; M Ikuma; T Hoshi; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

3.  The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.

Authors:  Monika Kloch; Michał Milewski; Ewa Nurowska; Beata Dworakowska; Garry R Cutting; Krzysztof Dołowy
Journal:  Cell Physiol Biochem       Date:  2010-01-12

4.  Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.

Authors:  Allan L Berger; Mutsuhiro Ikuma; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

Review 5.  The ABC protein turned chloride channel whose failure causes cystic fibrosis.

Authors:  David C Gadsby; Paola Vergani; László Csanády
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

Review 6.  Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

7.  A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating.

Authors:  J Fu; H L Ji; A P Naren; K L Kirk
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

Review 8.  Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.

Authors:  Daniella Muallem; Paola Vergani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

9.  Direct effects of 9-anthracene compounds on cystic fibrosis transmembrane conductance regulator gating.

Authors:  Tomohiko Ai; Silvia G Bompadre; Yoshiro Sohma; Xiaohui Wang; Min Li; Tzyh-Chang Hwang
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

10.  Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.

Authors:  Jeng-Haur Chen; Zhiwei Cai; David N Sheppard
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.